Capital Investment Advisors’s Linde LIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$957K Buy
1,843
+44
+2% +$22.3K 0.01% 374
2026
Q1
$892K Buy
1,799
+435
+32% +$205K 0.01% 367
2025
Q4
$581K Buy
1,364
+9
+0.7% +$3.85K 0.01% 448
2025
Q3
$644K Sell
1,355
-85
-6% -$40.2K 0.01% 424
2025
Q2
$675K Sell
1,440
-66
-4% -$30.1K 0.01% 407
2025
Q1
$701K Buy
1,506
+300
+25% +$135K 0.01% 380
2024
Q4
$505K Buy
1,206
+157
+15% +$71.5K 0.01% 419
2024
Q3
$500K Buy
1,049
+66
+7% +$30.1K 0.01% 408
2024
Q2
$431K Buy
983
+513
+109% +$226K 0.01% 425
2024
Q1
$218K Buy
+470
New +$204K 0.01% 568
2023
Q4
– Sell
-625
Closed -$233K – 639
2023
Q3
$233K Buy
+625
New +$238K 0.01% 517
2023
Q2
– Sell
-589
Closed -$209K – 582
2023
Q1
$209K Buy
+589
New +$197K 0.01% 512
2022
Q3
– Sell
-939
Closed -$270K – 561
2022
Q2
$270K Buy
939
+41
+5% +$12.8K 0.01% 459
2022
Q1
$287K Buy
898
+10
+1% +$3.09K 0.01% 467
2021
Q4
$308K Buy
888
+19
+2% +$6.16K 0.01% 451
2021
Q3
$255K Buy
+869
New +$264K 0.01% 484

Other funds holding LIN

Capital Investment Advisors's LIN Position: Q2 2026 in Review

Capital Investment Advisors increased its Linde (LIN) stake by 2.4% in Q2 2026, buying an estimated $22.3K and bringing the position to 1,843 shares worth $957K. The position accounts for 0.01% of the portfolio, ranked #374.

Capital Investment Advisors first reported a position in LIN in Q3 2021 and has held it in 16 quarters since. 2,350 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • Capital Investment Advisors held 1,843 shares of Linde worth $957K as of Q2 2026.
  • Capital Investment Advisors bought 44 Linde shares in Q2 2026, an estimated $22.3K.
  • Linde made up 0.01% of Capital Investment Advisors's portfolio in Q2 2026, its #374 holding.
  • Capital Investment Advisors first reported a position in Linde in Q3 2021 and has held it in 16 quarters since.
  • 2,350 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Capital Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.